With nine million new cases appearing every year, tuberculosis (TB) is far from a disease of the past. We sat down with Jeffrey Cirillo, Ph.D., professor at the Texas A&M Health Science Center College of Medicine, who has spent the last 28 years researching tuberculosis, to find out more about one of the world’s deadliest infectious diseases.
A critical challenge in the TB fight is the reality that the disease hits citizens hardest in areas with the least resources to fight it. Participants at the George H.W. Bush Sixth China-U.S. Relations Conference in Houston are intent on solving this global challenge with advancements in diagnosis and treatment that can potentially benefit all the world’s citizens.
New, rapid point-of-care TB test dramatically reduces the current delays in diagnosis with incredible accuracy, accelerating appropriate treatment and reducing the death rate of the highly infectious disease. Low-cost, easy-to-use test has the potential to eradicate TB.
A growing team of researchers in the Texas A&M College of Medicine is trying to understand the basic mechanisms of how the immune system works. This knowledge could be used to develop new treatments for diseases such as multiple sclerosis and inflammatory bowel disease (IBD). It also has broad implications for infectious diseases such as tuberculosis.
A new test for tuberculosis (TB) could dramatically improve the speed and accuracy of diagnosis for one of the world’s deadliest diseases, enabling health care providers to report results to patients within minutes.
For the past six years, Dr. Jeffery Cirillo and his team of researchers at the Texas A&M Health Science Center College of Medicine have been chasing a dream: To shorten the diagnosis timeline for tuberculosis (TB), one of the world’s deadliest diseases, from several weeks down to just a few hours.